Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
Biotech startup Cantai Therapeutics raises $3M
Another local biotech company is starting 2026 with fresh cash. Cantai Therapeutics — which operates on a virtual…
U.S. names HIV, arthritis drugs for next Medicare price talks
Eli Lilly’s office in San Diego, Nov. 21, 2025. Mike Blake | Reuters The U.S. government on Tuesday…
UnitedHealth Group (UNH) earnings Q4 2025
UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US,…
Number of new U.S. drug shortages hits lowest level in 20 years
The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
Twisted graphene puts magnetic fields in check
A graphene-based quantum sensor uses two decoupled layers to form a quantized 4 × 4 Landau-level checkerboard when…
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
Novo Nordisk, Pfizer execs weigh in
President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, Dec.…
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
Secretive Project Prometheus takes VC Bob Nelsen beyond just health care
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…